Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Haematologica|July 18, 2000
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's diseaseP G Gobbi, C Broglia, R Bertè, et al.
European Journal of Neurology|May 15, 2014
Large deletion mutation of SPAST in a multi-generation family from SardiniaL Racis, R Di Fabio, A Tessa, et al.
Blood|May 16, 1998
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's diseaseP G Gobbi, C Pieresca, M L Ghirardelli, et al.
Haematologica|April 11, 2000
The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomasP G Gobbi, M L Ghirardelli, C Cavalli, et al.
British Journal of Cancer|March 1, 1996
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple MyelomaS Brugnatelli, A Riccardi, G Ucci, et al.
International Journal of Oncology|May 12, 2011
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myelomaA Riccardi, G Ucci, S Brugnatelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Image-aided estimate of tumor burden in Hodgkin's disease: evidence of its primary prognostic importanceP G Gobbi, M L Ghirardelli, M Solcia, et al.
Tumori|December 23, 1998
Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast CancerA Riccardi, S Brugnatelli, M Giordano, et al.
International Journal of Clinical & Laboratory Research|August 5, 1998
The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapyF Dammacco, F Silvestris, G L Castoldi, et al.
British Journal of Cancer|February 7, 2001
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple MyelomaA Riccardi, O Mora, C Tinelli, et al.
Pageof 20